Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech BioPharma DiveThrough two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it s accrued.Read full story pharminent April 29, 2026 (Last updated: April 30, 2026) BioPharma Dive Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it s accrued. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Pfizer settles with generic drugmakers to protect blockbuster drug until 2031Next: Chiesi to buy KalVista in $1.9B deal for rare disease drug Related Stories Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026 Other 225: An Interview With Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator pharminent May 18, 2026 Other Cellbxhealth partners with AdventHealth on CTCbased monitoring in two major cancer studies pharminent May 18, 2026
